A method for preparing trisodium ascorbate palmitate phosphate
By using a synergistic effect of a eutectic solvent and a magnetically supported catalyst, trisodium ascorbate palmitate phosphate was prepared, solving the safety and post-processing complexity issues of esterification reactions in existing technologies. This resulted in a highly efficient and environmentally friendly esterification reaction suitable for industrial applications.
Patent Information
- Application Number
- CN202611384531.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-09-08
- Publication Date
- 2026-11-17
AI Technical Summary
Existing technologies for preparing trisodium ascorbate palmitate phosphate have problems such as the use of highly corrosive reagents, high operational risks, harsh reaction conditions, complex post-processing, and difficulty in separating by-products and solvent residues.
Ascorbate palmitate trisodium phosphate was prepared by esterification using a eutectic solvent system and a magnetically supported catalyst. Choline chloride-ethylene glycol eutectic solvent was used as the reaction medium, magnetic Fe3O4@SiO2 core-shell particles were used as the catalyst, and onium salt condensing agents were combined to achieve efficient esterification.
It achieves a green and environmentally friendly esterification reaction with high catalytic efficiency, simple post-processing, and high product purity, making it suitable for industrial production and reducing environmental pollution risks and production costs.
Smart Images

Figure SMS_1
Abstract
Description
Technical Field
[0001] This invention relates to a method for preparing trisodium ascorbate palmitate phosphate, belonging to the field of chemical synthesis technology. Background Technology
[0002] Trisodium ascorbyl palmitate phosphate (APPS, CAS number 302345-18-2) is a vitamin C derivative that is both hydrophilic and fat-soluble. Its molecular structure contains both phosphate ester groups and long-chain fatty acid ester groups, which retains the antioxidant activity of vitamin C while improving its fat solubility. In cosmetics, it is used as an antioxidant and whitening ingredient, which can effectively scavenge free radicals and inhibit melanin production. In the food industry, it can be used as a nutritional fortifier and antioxidant. Compared with vitamin C, APPS has better stability, compatibility and transdermal absorption.
[0003] The palmitate bonds in the molecular structure of APPS can be synthesized via acyl chloride or esterification. Acyl chloride can be used as a raw material, reacting L-ascorbic acid-2-phosphate and palmitoyl chloride under DMAP catalysis (to obtain L-ascorbic acid-2-phosphate-6-palmitate, its sodium salt form being trisodium ascorbate palmitate phosphate). However, the acyl chloride method requires the use of highly corrosive reagents such as thionyl chloride and phosphorus trichloride, placing high demands on equipment and posing significant operational risks. Furthermore, the acyl chloride intermediate generated during the reaction is highly reactive and readily reacts with water, requiring a strictly anhydrous reaction system and stringent operating conditions. In addition, the reaction produces acidic byproducts such as hydrogen chloride, making post-processing complex.
[0004] Esterification can be achieved through the esterification reaction between sodium ascorbate phosphate (SAP) and palmitic acid. Esterification is a classic method for the reaction of carboxylic acids with alcohols to form esters, offering advantages over acyl chloride methods in terms of higher atom economy and fewer byproducts. However, the key challenge in the synthesis of APPS lies in the fact that SAP molecules contain multiple hydroxyl groups (including enediol hydroxyl and phosphate ester hydroxyl groups), while palmitic acid is a long-chain fatty acid. The significant differences in polarity and solubility between the two lead to low mass transfer efficiency. Furthermore, SAP is sensitive to heat and oxygen, and is prone to oxidative degradation under high temperatures; therefore, the esterification reaction must be carried out under mild conditions. To address this issue, condensing agent / activator-mediated esterification strategies are commonly used in the field. The basic principle of this method is that a highly reactive intermediate (such as anhydride, reactive ester, etc.) is formed by reacting a condensing agent or activator with a carboxylic acid, followed by a nucleophilic substitution reaction with an alcohol (or phenol) under relatively mild conditions to form an ester bond. Commonly used condensing agent / activator systems mainly include carbodiimide condensing agent systems (such as N,N'-dicyclohexylcarbodiimide (DCC), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC·HCl), etc.), often used in combination with 4-dimethylaminopyridine (DMAP) or 1-hydroxybenzotriazole (HOBt). These systems form an O-acylisourea intermediate through the reaction of carbodiimide with a carboxylic acid, which is then further reacted with... Esterification reactions can be formed by alcohol reactions and by onium salt condensing agent systems (such as benzotriazol-1-yl-oxytripyrrolidinylphosphonium hexafluorophosphate (PyBOP), O-(7-azabenzotriazol-1-yl)-N,N,N',N'-tetramethylurea hexafluorophosphate (HATU), tetramethylchloroformamidine hexafluorophosphate (TCFH), etc., which are often used in combination with organic bases to promote esterification reactions by forming highly active O-acylisourea onium salt intermediates).
[0005] However, esterification reactions mediated by condensing agents / activators still have certain drawbacks. For example, the catalyst / condensing agent is a homogeneous system and dissolves in the reaction medium after the reaction. Complex separation methods such as column chromatography and preparative high-performance liquid chromatography are usually required to remove it from the product, resulting in a lengthy and costly post-processing procedure. Byproducts generated by the condensing agent reaction (such as urea compounds and onium salt derivatives) are similar to the amphiphilic APPS products in terms of polarity and solubility, making it difficult to achieve complete separation by simple solvent extraction or recrystallization. Existing processes often use volatile organic solvents such as dichloromethane and N,N-dimethylformamide as the reaction medium, which poses risks of environmental pollution and solvent residue.
[0006] Therefore, it is necessary to develop a green, environmentally friendly, and easy-to-process method for preparing trisodium ascorbate palmitate phosphate. Summary of the Invention
[0007] In view of the above-mentioned problems in the prior art, the purpose of this invention is to provide a method for preparing trisodium ascorbate palmitate phosphate.
[0008] To achieve the above objectives, the present invention adopts the following technical solution: A method for preparing trisodium ascorbate palmitate phosphate involves using sodium ascorbate phosphate (SAP) and palmitic acid as raw materials, and carrying out an esterification reaction in a eutectic solvent system under the action of a magnetically supported catalyst and an onium salt condensing agent to prepare trisodium ascorbate palmitate phosphate. The eutectic solvent system is a choline chloride-ethylene glycol system, with a molar ratio of choline chloride to ethylene glycol of 1:2-1:5. The magnetically supported catalyst is prepared by surface-initiated atom transfer radical polymerization grafting of polyvinyl imidazole brush layer onto Fe3O4@SiO2 core-shell particles after successively undergoing 3-aminopropyltriethoxysilane amino functionalization and 2-bromoisobutyryl bromide initiator. The Fe3O4@SiO2 core-shell particles are obtained by coating a SiO2 shell onto the surface of Fe3O4 magnetic nanoparticles as the core.
[0009] In one embodiment, the onium salt condensing agent is N,N,N',N'-tetramethylchloroformamidine hexafluorophosphate (TCFH).
[0010] In one embodiment, during the preparation of trisodium ascorbate palmitate phosphate, the molar ratio of sodium ascorbate phosphate (SAP) to palmitic acid is 1:0.5-1.0, the molar ratio of onium salt condensing agent to sodium ascorbate phosphate (SAP) is 1.5-2.5:1, and the amount of magnetically supported catalyst is 20-40% of the mass of sodium ascorbate phosphate (SAP).
[0011] In one embodiment, the preparation process of trisodium ascorbate palmitate phosphate involves first mixing sodium ascorbate phosphate (SAP), palmitic acid, a magnetically supported catalyst, and a eutectic solvent evenly, then cooling the mixture to 0-5°C, adding an onium salt condensing agent, and then performing an esterification reaction at 20-40°C for 8-24 hours to obtain trisodium ascorbate palmitate phosphate.
[0012] In one embodiment, after the esterification reaction is completed, the reaction solution is magnetically filtered to separate and remove the magnetically supported catalyst. The filtrate is diluted with deionized water to 3-5 times the original volume and extracted with ethyl acetate 2-4 times (the volume ratio of ethyl acetate to the reaction solution is 1-3:1). The organic phases are combined and washed 1-3 times with saturated sodium bicarbonate and 1-3 times with saturated brine. After drying with anhydrous sodium sulfate, the solution is concentrated under reduced pressure to 1 / 5-1 / 10 of the original volume. The resulting concentrate is slowly added dropwise to 5-10 times the volume of cold n-hexane (0-5°C), and the solid is stirred to precipitate. The solid is filtered, the filter cake is washed with cold n-hexane, and dried to obtain pure trisodium ascorbate palmitate phosphate.
[0013] One embodiment of the magnetically supported catalyst includes the following steps: 1) Fe3O4 magnetic nanoparticles were coated with SiO2 using the Stöber method to obtain Fe3O4@SiO2 core-shell particles; 2) Disperse Fe3O4@SiO2 core-shell particles in anhydrous toluene, add 3-aminopropyltriethoxysilane (APTES), and reflux at 110-120℃ for 24-48 hours under nitrogen protection. After the reaction is completed, magnetic separation, washing, and drying are performed to obtain amino-functionalized magnetic particles, denoted as Fe3O4@SiO2-NH2. 3) Fe3O4@SiO2-NH2 was dispersed in anhydrous tetrahydrofuran, and triethylamine and 2-bromoisobutyryl bromide (BiBB) were added sequentially at 0-5℃. The reaction was carried out at room temperature for 24-48 hours. After the reaction was completed, the particles were magnetically separated, washed, and dried to obtain magnetic particles with initiators on their surface, which were denoted as Fe3O4@SiO2-Br. 4) Fe3O4@SiO2-Br, N-vinylimidazolium (i.e., 1-vinylimidazolium), cuprous bromide (CuBr) and 2,2'-bipyridine (Bpy) were added to the reactor, and a methanol / water mixture (volume ratio 3:1-5:1) was added. After degassing by freezing-vacuuming-thawing cycle, the reaction was carried out at 30-40℃ for 48-72 hours. After the reaction was completed, the catalyst was magnetically separated, washed (specifically, washed sequentially with methanol, EDTA solution and deionized water), and dried to obtain the magnetically immobilized catalyst. In the magnetically supported catalyst of this invention, a polyvinyl imidazole brush layer is grafted onto the surface of Fe3O4@SiO2 core-shell particles. The active catalyst center, vinyl imidazole, is supported on the Fe3O4@SiO2 core-shell particles, which not only makes the catalyst paramagnetic, but also allows it to be easily separated and recovered from the reaction solution by magnetic separation after the reaction. At the same time, the imidazole groups in the polyvinyl imidazole brush layer retain the complete NH structure, which not only functions as an acid-binding agent, but also has a nucleophilic catalytic function that synergistically activates palmitic acid with the onium salt condensing agent TCFH to generate a highly active N-acylimidazolium salt intermediate. Furthermore, the high-density arrangement of imidazole groups in the polymer brush layer forms a "catalytic enrichment zone", which can accelerate the formation of the highly active N-acylimidazolium salt intermediate and promote the coupling reaction between the intermediate and SAP, thereby improving the overall esterification efficiency.
[0014] In this invention, the Fe3O4 magnetic nanoparticles can be commercially available or prepared in-house. For example, Fe3O4 magnetic nanoparticles can be prepared in-house using a solvothermal method, specifically: FeCl3·6H2O is dissolved in ethylene glycol, sodium acetate and polyethylene glycol are added, the mixture is ultrasonically dispersed, and then transferred to a reaction vessel. The reaction is carried out at 180-200℃ for 8-12 hours. After the reaction, the nanoparticles are magnetically separated, washed, and dried to obtain Fe3O4 magnetic nanoparticles. The mass ratio of FeCl3·6H2O:sodium acetate:polyethylene glycol is 1:2-3:0.5-1.
[0015] In a preferred embodiment, step 1) involves the following steps in preparing Fe3O4@SiO2 core-shell particles: dispersing Fe3O4 magnetic nanoparticles in an ethanol / water mixed solution (volume ratio 4:1), adding ammonia and tetraethyl orthosilicate (TEOS), stirring at room temperature for 6-12 hours, and after the reaction is completed, magnetic separation, washing, and drying are performed to obtain Fe3O4@SiO2 core-shell particles, wherein the mass ratio of tetraethyl orthosilicate to Fe3O4 magnetic nanoparticles is 1-3:1.
[0016] In a preferred embodiment, in step 2), the mass ratio of 3-aminopropyltriethoxysilane (APTES):Fe3O4@SiO2 core-shell particles is 0.5-1.5:1.
[0017] In a preferred embodiment, in step 3), the molar ratio of triethylamine to 2-bromoisobutyryl bromide is 1.2-1.5:1; and the mass ratio of 2-bromoisobutyryl bromide to Fe3O4@SiO2-NH2 is 0.5-1:1.
[0018] In a preferred embodiment, in step 4), the mass ratio of N-vinylimidazolium to Fe3O4@SiO2-Br is 5-15:1; the molar ratio of cuprous bromide (CuBr) to 2,2'-bipyridine (Bpy) is 1:2-4.
[0019] In one embodiment, the method for preparing the eutectic solvent is as follows: Choline chloride (ChCl) and ethylene glycol (EG) are mixed in a molar ratio of 1:2 to 1:5 and stirred and heated at 60-80°C for 1-3 hours until a homogeneous and transparent liquid is formed, thus obtaining a eutectic solvent.
[0020] This invention uses a eutectic solvent formed by choline chloride (ChCl) and ethylene glycol (EG) to replace traditional organic solvents as the reaction medium, which is green and environmentally friendly and overcomes the environmental pollution problems of traditional organic solvents. Furthermore, this eutectic solvent also exhibits a synergistic effect with the magnetically supported catalyst: the choline chloride-ethylene glycol system (DES) has a moderate viscosity, and its hydrogen bond network allows the polyvinyl imidazole brush layer on the surface of the magnetically supported catalyst to fully extend, significantly improving the accessibility of the active sites of the supported vinyl imidazole. At the same time, DES, acting as both a hydrogen bond donor and acceptor, promotes chain segment movement through intermolecular hydrogen bond interactions with the polymer brush layer, making the catalytic efficiency close to the homogeneous level. In addition, the hydrogen bond network of DES can stabilize the acyl imidazole onium salt intermediate generated by the reaction of the onium salt condenser TCFH with vinyl imidazole, reducing the activation energy of the reaction. Furthermore, the hydroxyl groups of ethylene glycol in this eutectic solvent can interact with the phosphate ester groups of the target product APPS through hydrogen bonding, thereby preferentially solubilizing APPS molecules during the reaction, achieving an "in-situ extraction" effect, inhibiting the formation of byproducts, and improving reaction selectivity.
[0021] Compared with the prior art, the present invention has the following significant advantages: This invention uses sodium ascorbate phosphate (SAP) and palmitic acid as raw materials to prepare trisodium ascorbate palmitate phosphate through esterification in a eutectic solvent system under the action of a magnetically supported catalyst and an onium salt condensing agent. The magnetically supported catalyst is prepared by surface-initiated atom transfer radical polymerization grafting of polyvinyl imidazole onto Fe3O4@SiO2 core-shell particles after amino functionalization with 3-aminopropyltriethoxysilane and immobilization with a 2-bromoisobutyryl bromide initiator. The eutectic solvent, magnetically supported catalyst, and onium salt condensing agent exhibit synergistic effects, resulting in high catalytic efficiency, mild reaction conditions, and environmental friendliness. After the reaction, the catalyst can be removed by simple magnetic separation, eliminating the need for column chromatography. High-purity target products can be obtained simply through extraction washing and antisolvent precipitation. The post-processing is convenient, suitable for industrial production, and has significant industrial application value. Detailed Implementation
[0022] The technical solution of the present invention will be further described in detail and completely below with reference to the embodiments. It should be understood that these embodiments are only used to illustrate the present invention and are not intended to limit the scope of the present invention. Experimental methods in the following embodiments that do not specify specific conditions are generally performed under conventional conditions or as recommended by the manufacturer. Example 1
[0023] I. Preparation of Magnetic Immobilized Catalysts 1) Dissolve 1.35g FeCl3·6H2O in 40mL ethylene glycol, add 3.6g sodium acetate and 1.0g polyethylene glycol, sonicate for 30 minutes and then transfer to a reaction vessel. React at 200℃ for 8 hours. After the reaction is completed, magnetic separation, washing and drying are performed to obtain Fe3O4 magnetic nanoparticles. 0.5 g of Fe3O4 magnetic nanoparticles were dispersed in 50 mL of ethanol / water mixed solution (volume ratio 4:1), 2 mL of ammonia and 1 mL of tetraethyl orthosilicate (TEOS) were added, and the mixture was stirred at room temperature for 10 hours. After the reaction was completed, the nanoparticles were magnetically separated, washed, and dried to obtain Fe3O4@SiO2 core-shell particles. 2) 0.3 g of Fe3O4@SiO2 core-shell particles were dispersed in 20 mL of anhydrous toluene, and 0.5 mL of 3-aminopropyltriethoxysilane (APTES) was added. The mixture was refluxed at 110 °C for 36 hours under nitrogen protection. After the reaction was completed, the particles were magnetically separated, washed, and dried to obtain amino-functionalized magnetic particles, denoted as Fe3O4@SiO2-NH2. 3) 0.2 g Fe3O4@SiO2-NH2 was dispersed in 15 mL of anhydrous tetrahydrofuran. 0.3 mL of triethylamine and 0.2 mL of 2-bromoisobutyryl bromide (BiBB) were added sequentially at 0-5 °C. The reaction was carried out at room temperature for 36 hours. After the reaction was completed, the particles were magnetically separated, washed, and dried to obtain magnetic particles with an initiator on their surface, which were denoted as Fe3O4@SiO2-Br. 4) 0.1 g Fe3O4@SiO2-Br, 1.0 g N-vinylimidazolium, 15 mg cuprous bromide (CuBr) and 50 mg 2,2'-bipyridine (Bpy) were added to the reactor, and 8 mL of methanol / water mixed solution (volume ratio 3:1) was added. After degassing by three cycles of freezing-vacuuming-thawing, the reaction was carried out at 35 °C for 60 hours. After the reaction was completed, the mixture was magnetically separated, washed successively with methanol, EDTA solution and deionized water, and dried under vacuum to obtain the magnetically immobilized catalyst.
[0024] II. Preparation of Eutectic Solvents Choline chloride and ethylene glycol were mixed in a molar ratio of 1:2 and stirred and heated at 80°C for 2 hours until a homogeneous and transparent liquid was formed, thus obtaining a eutectic solvent.
[0025] III. Preparation of trisodium ascorbate palmitate phosphate
[0026] Add 10 mL of choline chloride-ethylene glycol eutectic solvent to a reaction flask. While stirring, add 1.0 g of sodium ascorbate phosphate (SAP, approximately 3.1 mmol), 0.3 g of magnetically supported catalyst, and 0.75 g of palmitic acid. Mix thoroughly and cool to 0-5 °C. Slowly add 2.09 g of tetramethylchloromethanesulfonyl hexafluorophosphate (TCFH, approximately 7.45 mmol). After addition, stir the reaction mixture at room temperature for 12 hours. After the reaction is complete, magnetically filter the reaction solution to remove the magnetically supported catalyst. Dilute the filtrate with 30 mL of deionized water and extract three times with ethyl acetate (30 mL each time). Combine the organic phases and wash them twice with saturated NaHCO3 solution and twice with saturated brine. Dry under anhydrous Na2SO4 and concentrate under reduced pressure to approximately 3 mL. Slowly add the concentrate dropwise to 20 mL of cold n-hexane (0-5 °C). The solid was stirred and precipitated, filtered, and the filter cake was washed with cold n-hexane and dried under vacuum at 40℃ to obtain trisodium ascorbate palmitate phosphate (yield 91.2%). The purity of the product was determined by high performance liquid chromatography (HPLC). The chromatographic conditions were: C18 column (4.6×250mm, 5μm), mobile phase acetonitrile / water (containing 0.1% phosphoric acid) = 65:35 (v / v), flow rate 1.0mL / min, detection wavelength 254nm, column temperature 30℃, and the HPLC purity of the product was found to be 98.5%. Example 2
[0027] The difference between this embodiment and Example 1 is that: when preparing trisodium ascorbate palmitate phosphate, the molar ratio of SAP to palmitic acid is 1:0.8, the reaction temperature is 35°C, the reaction time is 16 hours, and other conditions are the same as in Example 1; the yield of the obtained trisodium ascorbate palmitate phosphate is 93.4%, and the HPLC purity is 98.7%. Example 3
[0028] The difference between this embodiment and Example 1 is that: when preparing trisodium ascorbate palmitate phosphate, the molar ratio of TCFH to SAP is 2.0:1, the molar ratio of choline chloride to ethylene glycol in the eutectic solvent is 1:4, and other conditions are the same as in Example 1; the yield of the obtained trisodium ascorbate palmitate phosphate is 92.8%, and the HPLC purity is 98.3%.
[0029] Comparative Example 1 The difference between this comparative example and Example 1 is that the solvent used in the preparation of trisodium ascorbate palmitate phosphate is dichloromethane, and the catalytic system used is N-methylimidazolium (NMI) and tetramethylchloromethanesulfonium hexafluorophosphate (TCFH). The specific preparation method is as follows: Add 20 mL of anhydrous dichloromethane to a reaction flask, and while stirring, add 1.0 g of sodium ascorbate phosphate (SAP, approx. 3.1 mmol), 0.75 g of palmitic acid (approx. 2.9 mmol), and 0.3 g of N-methylimidazole (NMI, approx. 3.7 mmol). Mix well, cool to 0-5 °C, and slowly add 2.09 g of tetramethylchloromethanesulfonyl hexafluorophosphate (TCFH, approx. 7.45 mmol). Stir the reaction at room temperature for 12 hours. After the reaction is complete, wash the reaction solution twice with deionized water and once with saturated brine. Dry the organic phase with anhydrous Na2SO4 and concentrate under reduced pressure. The crude product is purified by silica gel column chromatography (eluting agent: ethyl acetate / petroleum ether = 1:4-1:1 gradient elution) to obtain trisodium ascorbate palmitate phosphate (yield 88.5%, HPLC purity 98.2%).
[0030] As can be seen from Example 1 and Comparative Example 1, the preparation of trisodium ascorbate palmitate phosphate using a magnetically supported catalyst and a eutectic solvent system is a green and environmentally friendly method compared to the preparation method using the NMI / TCFH catalytic system and dichloromethane solvent. It eliminates the need for the organic solvent dichloromethane. After the reaction, no column chromatography is required; only extraction, washing, and antisolvent precipitation are needed to obtain a high-purity product with a higher yield.
[0031] Finally, it should be noted that the above are only some preferred embodiments of the present invention and should not be construed as limiting the scope of protection of the present invention. Any non-essential improvements and adjustments made by those skilled in the art based on the above content of the present invention shall fall within the scope of protection of the present invention.
Claims
1. A method for preparing trisodium ascorbate palmitate phosphate, characterized in that, Ascorbate palmitate trisodium phosphate is prepared by esterification reaction of sodium ascorbate phosphate and palmitic acid in a eutectic solvent system under the action of magnetically supported catalyst and onium salt condensing agent. The eutectic solvent system is a choline chloride-ethylene glycol system, with a molar ratio of choline chloride to ethylene glycol of 1:2-1:
5. The magnetically supported catalyst is prepared by surface-initiated atom transfer radical polymerization grafting of polyvinyl imidazole brush layer onto Fe3O4@SiO2 core-shell particles after successively undergoing 3-aminopropyltriethoxysilane amino functionalization and 2-bromoisobutyryl bromide initiator. The Fe3O4@SiO2 core-shell particles are obtained by coating a SiO2 shell onto the surface of Fe3O4 magnetic nanoparticles as the core.
2. The method for preparing trisodium ascorbate palmitate phosphate according to claim 1, characterized in that, The onium salt condensing agent is N,N,N',N'-tetramethylchloroformamidine hexafluorophosphate.
3. The method for preparing trisodium ascorbate palmitate phosphate according to claim 1, characterized in that, In the preparation of trisodium ascorbate palmitate phosphate, the molar ratio of sodium ascorbate phosphate to palmitic acid is 1:0.5-1.0, the molar ratio of onium salt condensing agent to sodium ascorbate phosphate is 1.5-2.5:1, and the amount of magnetically supported catalyst is 20-40% of the mass of sodium ascorbate phosphate.
4. The method for preparing trisodium ascorbate palmitate phosphate according to claim 1, characterized in that, The preparation of the magnetically supported catalyst includes the following steps: 1) Fe3O4 magnetic nanoparticles were coated with SiO2 using the Stöber method to obtain Fe3O4@SiO2 core-shell particles; 2) Disperse Fe3O4@SiO2 core-shell particles in anhydrous toluene, add 3-aminopropyltriethoxysilane, and reflux at 110-120℃ for 24-48 hours under nitrogen protection. After the reaction is completed, magnetic separation, washing and drying are performed to obtain amino-functionalized magnetic particles, denoted as Fe3O4@SiO2-NH2. 3) Fe3O4@SiO2-NH2 was dispersed in anhydrous tetrahydrofuran, and triethylamine and 2-bromoisobutyryl bromide were added sequentially at 0-5℃. The reaction was carried out at room temperature for 24-48 hours. After the reaction was completed, the particles were magnetically separated, washed, and dried to obtain magnetic particles with initiators on their surface, which were denoted as Fe3O4@SiO2-Br. 4) Fe3O4@SiO2-Br, N-vinylimidazolium, cuprous bromide and 2,2'-bipyridine were added to the reactor, and a methanol / water mixture was added. After degassing by freezing-vacuuming-thawing cycle, the reaction was carried out at 30-40℃ for 48-72 hours. After the reaction was completed, the catalyst was magnetically separated, washed and dried to obtain the magnetically supported catalyst.
5. The method for preparing trisodium ascorbate palmitate phosphate according to claim 4, characterized in that, In step 1), the preparation of Fe3O4@SiO2 core-shell particles includes the following operations: Fe3O4 magnetic nanoparticles are dispersed in an ethanol / water mixed solution, ammonia and tetraethyl orthosilicate are added, and the mixture is stirred at room temperature for 6-12 hours. After the reaction is completed, the particles are magnetically separated, washed, and dried to obtain Fe3O4@SiO2 core-shell particles.
6. The method for preparing trisodium ascorbate palmitate phosphate according to claim 5, characterized in that, In step 1), the mass ratio of tetraethyl orthosilicate to Fe3O4 magnetic nanoparticles is 1-3:
1.
7. The method for preparing trisodium ascorbate palmitate phosphate according to claim 4, characterized in that, In step 2), the mass ratio of 3-aminopropyltriethoxysilane to Fe3O4@SiO2 core-shell particles is 0.5-1.5:
1.
8. The method for preparing trisodium ascorbate palmitate phosphate according to claim 4, characterized in that, In step 3), the molar ratio of triethylamine to 2-bromoisobutyryl bromide is 1.2-1.5:1; the mass ratio of 2-bromoisobutyryl bromide to Fe3O4@SiO2-NH2 is 0.5-1:
1.
9. The method for preparing trisodium ascorbate palmitate phosphate according to claim 4, characterized in that, In step 4), the mass ratio of N-vinylimidazolium to Fe3O4@SiO2-Br is 5-15:1; the molar ratio of cuprous bromide to 2,2'-bipyridine is 1:2-4.
10. The method for preparing trisodium ascorbate palmitate phosphate according to claim 1, characterized in that, The method for preparing the eutectic solvent is as follows: choline chloride and ethylene glycol are mixed in a molar ratio of 1:2 to 1:5, and stirred and heated at 60-80°C for 1-3 hours until a homogeneous and transparent liquid is formed, thus obtaining the eutectic solvent.
